Research

The CCI awarded 18 seed grants to nine Virginia public universities for a total of $1.61M to address how artificial intelligence can make networks more secure, create new vulnerabilities, and more.

The CCI awarded 18 seed grants to nine Virginia public universities for a total of $1.61M to address how artificial intelligence can make networks more secure, create new vulnerabilities, and more.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.